Published on 24 Apr 2024 on Zacks via Yahoo Finance
Investors are always looking for stocks that are poised to beat at earnings season and BioMarin Pharmaceutical Inc. BMRN may be one such company. The firm has earnings coming up pretty soon, and events are shaping up quite nicely for their report.
That is because BioMarin is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat. After all, analysts raising estimates right before earnings — with the most up-to-date information possible — is a pretty good indicator of some favorable trends underneath the surface for BMRN in this report.